HRTS ETF (Tema Heart & Health ETF) is managed by Tema Global Limited with $51.5M in net assets. HRTS expense ratio is 0.75%, holding 45 positions across sectors including Health Care, Unknown, Other. Inception date: 2023-11-20.

HRTS performance shows a YTD return of -4.09%. The 1-year return is 26.27%. HRTS dividend yield stands at 1.38%, paid annually.

HRTS top holdings include Eli Lilly & Co (10.5%), UnitedHealth Group Incorporated (5.6%), Novo Nordisk As (5.4%), Roche Holdings Ag (4.5%), Merck & Company Inc (4.1%). View all HRTS holdings, sector breakdown, or dividend history.

HRTS can be compared against other funds using the overlap calculator or side-by-side comparison tool. HRTS alternatives are available via the screener, along with tax-loss harvesting opportunities.